文献速递神经创伤神经重症

低剂量早期新鲜冰冻血浆输注治疗重型创伤性脑损伤后:一项临床、前瞻性、随机对照研究

Low-Dose, Early Fresh Frozen Plasma Transfusion Therapy After Severe Trauma Brain Injury: A Clinical, Prospective, Randomized, Controlled Study.
PubMed 文献 · World Neurosurg · 2019-09-12

该前瞻性单中心随机对照试验纳入63例重型TBI患者,随机分为低剂量早期新鲜冰冻血浆(FFP)输注组(5 mL/kg)和生理盐水组(5 mL/kg)。因安全性和无效性提前终止,LEFT组术后新发迟发性创伤性颅内血肿比例显著高于NO LEFT组(35.0% vs 9.4%,RR 5.205,95%CI 1.159-23.384,P=0.023)。

要点

  • 低剂量早期FFP输注增加重型TBI术后迟发性颅内血肿风险(RR 5.205,P=0.023)。
  • 研究因安全性和无效性提前终止,提示限制性FFP输注策略可能更合适。
  • 两组基线人口学特征和脑损伤严重程度指数相似。

核心结论

  • 低剂量早期FFP输注与重型TBI患者术后迟发性创伤性颅内血肿发生率升高相关,高于生理盐水对照组。

研究设计与样本

  • 前瞻性、单中心、平行组、随机对照试验,纳入重型TBI患者,随机分配至FFP 5 mL/kg(LEFT组)或生理盐水5 mL/kg(NO LEFT组)。
  • 最终中期分析包括LEFT组20例和NO LEFT组32例,研究因无效性和安全性提前终止。

主要发现

  • LEFT组术后新发迟发性创伤性颅内血肿7/20(35.0%),NO LEFT组3/32(9.4%),相对风险5.205(95%CI 1.159-23.384,P=0.023)。
  • 两组基线人口学特征和脑损伤严重程度指数相似。

关键数值与推荐

  • FFP剂量:5 mL/kg体重;对照组生理盐水5 mL/kg体重。
  • 主要安全性终点:术后新发迟发性创伤性颅内血肿发生率,LEFT组35.0% vs NO LEFT组9.4%(RR 5.205,95%CI 1.159-23.384,P=0.023)。

临床怎么用

  • 对于重型TBI患者,低剂量早期FFP输注可能增加迟发性颅内血肿风险,需谨慎评估输注指征。
  • 在合适临床情境下,限制性FFP输注策略可能更为适宜。

局限性

  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To investigate role of Low-dose, Early Fresh frozen plasma Transfusion (LEFT) therapy in preventing perioperative coagulopathy and improving long-term outcome after severe traumatic brain injury (TBI). METHODS: A prospective, single-center, parallel-group, randomized trial was designed. Patients with severe TBI were eligible. We used a computer-generated randomization list and closed opaque envelops to randomly allocate patients to treatment with fresh frozen plasma (5 mL/kg body weight; LEFT group) or normal saline (5 mL/kg body weight; NO LEFT group) after admission in the operating room. RESULTS: Between January 1, 2018, and November 31, 2018, 63 patients were included and randomly allocated to LEFT (n = 28) and NO LEFT (n = 35) groups. The final interim analysis included 20 patients in the LEFT group and 32 patients in the NO LEFT group. The study was terminated early for futility and safety reasons because a high proportion of patients (7 of 20; 35.0%) in the LEFT group developed new delayed traumatic intracranial hematoma after surgery compared with the NO LEFT group (3 of 32; 9.4%) (relative risk, 5.205; 95% confidence interval, 1.159-23.384; P = 0.023). Demographic characteristics and indexes of severity of brain injury were similar at baseline. CONCLUSIONS: LEFT therapy was associated with a higher incidence of delayed traumatic intracranial hematoma than normal fresh frozen plasma transfusion in patients with severe TBI. A restricted fresh frozen plasma transfusion protocol, in the right clinical setting, may be more appropriate in patients with TBIs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhang LM, Li R, Sun WB, et al. Low-Dose, Early Fresh Frozen Plasma Transfusion Therapy After Severe Trauma Brain Injury: A Clinical, Prospective, Randomized, Controlled Study. World Neurosurg. 2019. PMID: 31521754. doi:10.1016/j.wneu.2019.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。